Jingwei Sun

Company: Grit Therapeutics

Job title: Senior Director of Early Discovery

Seminars:

The Discovery & Development of Next-Generation Long-Lasting Anti-Exhaustion TIL Therapies 1:30 pm

Design and development of function and persistence enhanced GT2 series TIL products engineered by StaViral® virus platform Development of GT3 series TIL products by CRISPR KO of potent immunoregulatory targets identified through ImmuT Finder®, a genome-wide CRISPR/Cas9 screening platform Preliminary safety and efficacy of next-gen TIL products in human trial as monotherapy in advanced solid…Read more

day: Conference Day One - Track A - PM